These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis]. Bao Q; Wang K; Wang HW; Jin KM; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993 [No Abstract] [Full Text] [Related]
8. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183 [TBL] [Abstract][Full Text] [Related]
10. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686 [TBL] [Abstract][Full Text] [Related]
11. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949 [TBL] [Abstract][Full Text] [Related]
13. Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years. Narayan RR; Aveson VG; Chou JF; Walch HS; Sanchez-Vega F; Santos Fernandes GD; Balachandran VP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC; Cercek A; Gönen M; Schultz N; Kingham TP J Surg Oncol; 2022 Apr; 125(5):880-888. PubMed ID: 35066881 [TBL] [Abstract][Full Text] [Related]
14. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550 [TBL] [Abstract][Full Text] [Related]
16. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival. Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988 [TBL] [Abstract][Full Text] [Related]
17. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases. Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866 [TBL] [Abstract][Full Text] [Related]
18. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy. Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066 [TBL] [Abstract][Full Text] [Related]
19. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130 [TBL] [Abstract][Full Text] [Related]
20. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases. Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]